Includes nurse practitioners as a provider of services for purposes of collaborative drug therapy management; makes the authorization for pharmacists to perform such management permanent.
Provides that insurance policies which provide hospital, surgical or medical coverage shall provide coverage for hysterectomies; provides that such coverage shall include inpatient hospital coverage for a minimum period of seventy-two hours after surgery.
Requires Medicaid to provide comprehensive coverage for the treatment of obesity including coverage for intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medication.
Relates to establishing the "340B prescription drug anti-discrimination act"; prohibits pharmaceutical manufacturers and pharmacy benefit managers from discriminating against covered entities and New York state pharmacies based on participation in the drug discount program authorized by section 340B of the federal public health service act.
This bill creates a state-run emergency insulin program to provide immediate access to analog insulin supplies for uninsured or underinsured people with type 1 or insulin-dependent type 2 diabetes who face serious health risks due to insulin shortages. It allows healthcare professionals and pharmacists to dispense insulin without a prescription during emergencies, requires large pharmacies to register as program participants by 2026, and caps costs at $100 for a 30-day supply. Funding comes from a new trust fund supported by manufacturer contributions and state appropriations, with the program required to be operational by April 2026. The program mandates annual reporting on participants, insulin types provided, costs, and public-private partnerships to the governor and health committees.
Provides for insurance coverage of comprehensive annual medical examinations for firefighters due to their increased risk for cancer and cancer-related diseases.
Requires health insurers to provide coverage for long term medical care for Lyme disease and other tick borne related pathogens; provides for taxpayer gifts for tick borne illness research, detection and education; establishes the tick borne illness research, detection and education fund.
This bill creates a revolving fund to support rural emergency first responders through grants for specialized training. It directly affects local police, fire, emergency services, hospitals, and agricultural safety organizations by providing affordable access to "farmedic" programs - training that combines classroom instruction with hands-on practice in real rural settings like farms and fields. The fund, financed through state appropriations and investment earnings, will cover eligible costs such as equipment, materials, and staff fees for qualifying organizations to expand their participation in these programs. Grantees must repay funds or use them as specified, ensuring the fund remains sustainable for ongoing rural emergency response training.
Sub-Topics
Hospitals
Tags
Emergency Management
This bill requires large group health insurance plans in New York to cover medically necessary hearing aids. It mandates reimbursement of up to $3,000 every 36 months for adults (16+), and $2,000 every 24 months for children under 16 (with medical documentation for changes in hearing needs). The coverage includes up to two hearing aids per period and services like recasing or new molds, but excludes batteries and cords. Insured individuals may choose more expensive devices but pay the difference beyond the reimbursement limits.
This bill requires health insurance plans to cover backup cochlear implant devices for patients who need them, including during device upgrades or replacements after the initial implant. It directly affects patients with cochlear implants who currently lose access to backup equipment after 3-5 years, as insurers only cover backups at the time of initial surgery. The law mandates that insurance must cover the backup device (external components like a processor) whenever prescribed by a qualified healthcare provider, as long as the patient is using the implant. Coverage will follow standard insurance terms like deductibles and copays but must remain available throughout the patient's need for the device, effective January 2027.